Subarachnoid hemorrhage

The Brain Aneurysm Foundation and Families of Individuals Impacted by the Disease Join Forces to Advocate for Increased Research Funding and Education

Retrieved on: 
Tuesday, March 19, 2024
Research, Organization, Myenteric plexus, Prevalence, Aneurysm, Disease, Intracranial aneurysm, Caregiver, Education, DSM-IV codes, Biomarker, Policy, Patient, University, Death, Risk, Rupture, Tutino, Survivor, Subarachnoid hemorrhage, NINDS, Biomedical sciences, Murder of Ellie Gould, Bangladesh Technical Education Board, Family, Physician, Health, Pharmaceutical industry

HANOVER, Mass., March 19, 2024 /PRNewswire/ -- The Brain Aneurysm Foundation (BAF), the leading advocacy organization supporting education, research, and policy to transform the treatment of brain aneurysms, today joined with caregivers, survivors, researchers, and physicians from across the U.S. to advocate for greater funding and to increase awareness of brain aneurysms and the long-term impact they can have on individuals and their families.

Key Points: 
  • Worldwide, there are close to 500,000 deaths each year from brain aneurysms, half of which occur in people under the age of 50.
  • The family's extensive work to honor Katelyn, who died just months before her planned wedding, has led to their involvement in supporting increased funding for critical research.
  • 902 and S. 895), which would provide dedicated research for aneurysm prevention and improve the long-term outcomes for aneurysm survivors.
  • "Brain scans can be cost prohibitive and are often not recommended by a physician unless there is a family history of the disease.

External Ventricular Drain Market to Record a Growth of USD 2.28 billion between 2023 and 2028, North America to Occupy 35% Market Share - Technavio

Retrieved on: 
Monday, January 29, 2024
ROW, Geography, Sleep apnea, Subarachnoid hemorrhage, Gene, Stroke, PD, Birth, Epilepsy, USD, Brain, Chromosome, Traumatic brain injury, DSM-IV codes, EVD, Intracerebral hemorrhage, Ageing, Prevalence, Growth, Pharmaceutical industry

NEW YORK, Jan. 29, 2024 /PRNewswire/ -- The external ventricular drain market is estimated to grow by USD 2.28 billion from 2023 to 2028 at a CAGR of 6.07% according to Technavio.

Key Points: 
  • NEW YORK, Jan. 29, 2024 /PRNewswire/ -- The external ventricular drain market is estimated to grow by USD 2.28 billion from 2023 to 2028 at a CAGR of 6.07% according to Technavio.
  • North America accounts for 35% of the growth of the global market during the forecast period.
  • The external ventricular drain market in North America is poised for rapid expansion, propelled by the increasing prevalence of neurological disorders, the upsurge in the aging population, and advancements in technology.
  • Within this growth trajectory, ischemic strokes stand out as a significant driver of industry progression.

CereVasc's eShunt® System Study Data Presented at the ABC WIN Seminar

Retrieved on: 
Tuesday, January 23, 2024
Hydrocephalus, Patient, Subarachnoid hemorrhage, ABC, DSM-IV codes, FDA, NPH, Treatment

BOSTON, Jan. 23, 2024 /PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that data from its clinical studies in the United States and Argentina, examining the use of its eShunt System to treat communicating hydrocephalus, was presented at the ABC WIN Seminar in Val d'Isere.

Key Points: 
  • BOSTON, Jan. 23, 2024 /PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that data from its clinical studies in the United States and Argentina, examining the use of its eShunt System to treat communicating hydrocephalus, was presented at the ABC WIN Seminar in Val d'Isere.
  • "We are pleased for our team to share the initial results of these thirty-one patients who have been treated with the eShunt System across multiple hydrocephalus etiologies and warrants the study of the device in a pivotal trial setting," said Dr. Pedro Lylyk, Director General of ENERI.
  • Dan Levangie, CereVasc President & CEO stated, "We are grateful to ABC WIN for the opportunity to have Dr. Lylyk present the encouraging data from our investigators in the trials of the eShunt System.
  • We are looking forward to leveraging the experience gained in these studies to support our pivotal study this year."

Brain Aneurysm Foundation Expands its Medical Advisory Board with Leading Experts from Brazil and Germany

Retrieved on: 
Wednesday, January 10, 2024
Rupture, Research, Interventional neuroradiology, Knowledge, Harvard Medical School, Intervention, Society, Risk, University Hospital Mannheim, Guideline, Professor, Paulo, Policy, Stroke, Global Reach, Disease, Congress, Skull, Radiology, Brain, Education, Physician, Aneurysm, CNS, Health, World government, Woman, Organization, Hospital, Death, Patient, Subarachnoid hemorrhage, ESO, Blood, Nursing

HANOVER, Mass., Jan. 10, 2024  /PRNewswire/ -- The Brain Aneurysm Foundation (BAF), the leading advocacy organization supporting education, research, and policy to transform the treatment of brain aneurysms, today announced it has appointed to its Medical Advisory Board Carlos Baccin, M.D., an interventional neuroradiologist and Director of the Institute of Radiology and NeuroIntervention in São Paulo, Brazil, and Nima Etminan, Professor and Chairman of the Department of Neurosurgery at University Hospital Mannheim, in Germany.

Key Points: 
  • Worldwide, there are close to 500,000 deaths each year from brain aneurysms, half of which occur in people under the age of 50.
  • Dr. Etminan has published over 120 papers in leading medical journals, primarily in the field of unruptured intracranial aneurysms or aneurysmal subarachnoid hemorrhage.
  • A brain aneurysm is a weak, bulging area in an artery in the brain that, in some instances, can rupture.
  • Women over the age of 55 have a higher risk of brain aneurysm rupture than men and are generally at greater risk.

Sosei Group Announces Marketing Approval for PIVLAZ™ (clazosentan sodium) 150 mg in South Korea

Retrieved on: 
Thursday, December 7, 2023
Marketing, Artery, Hospital, Cerebral vasospasm, Neurosurgery, Culture of Korea, IPJ, Rupture, Physician, Acquisition, Bleeding, Mortality, SubArachnoid Space, Brain, Incidence, Subarachnoid hemorrhage, Death, Ministry, Constriction, Aneurysm, IPK, Patient, MFDS, Pharmaceutical industry

Tokyo, Japan, Seoul, South Korea, and Cambridge, UK, 7 December 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) today announces that PIVLAZ™ (clazosentan sodium) 150 mg has received marketing approval from the Ministry of Food and Drug Safety (MFDS) in South Korea for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction, and cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage (aSAH) securing.

Key Points: 
  • Tokyo, Japan, Seoul, South Korea, and Cambridge, UK, 7 December 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) today announces that PIVLAZ™ (clazosentan sodium) 150 mg has received marketing approval from the Ministry of Food and Drug Safety (MFDS) in South Korea for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction, and cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage (aSAH) securing.
  • The MFDS approval is based on scientific and clinical data from an extensive Japanese Phase 3 program submitted by Idorsia Pharmaceuticals Korea (“IPK”), a Sosei Group company.
  • In South Korea, the Marketing Authorization of PIVLAZ™ is held by IPK and will become commercially available to patients in early 2025.
  • PIVLAZ™ received marketing approval in Japan in January 2022 and was launched in April 2022 by Idorsia Pharmaceuticals Japan ("IPJ”), also a Sosei Group company.

Memorial Neuroscience Institute Performs Livestreamed Brain Aneurysm Procedure

Retrieved on: 
Tuesday, November 14, 2023
Aneurysm, Human, DRS, Neck, Brain, Safety, Developed country, Memorial Regional Hospital (Florida), Mischer Neuroscience Institute, WEB, Spine, Mehta, Multimedia, Probability, Journal of NeuroInterventional Surgery, Subarachnoid hemorrhage, Memorial Hermann Health System, Abbott Northwestern Hospital, Neurology, Stroke, Neoplasm, Rehabilitation, Multiple sclerosis, Epilepsy, Neuroradiology, Family, Physician, Quality of life, Society, Medical imaging

HOLLYWOOD, Fla., Nov. 14, 2023 /PRNewswire-PRWeb/ -- Nearly 1,800 miles separated Dr. Brijesh Mehta and Dr. Josser Delgado during a recent procedure to treat a complex brain aneurysm, but that didn't mean the renowned neurologists weren't collaborating in real time.

Key Points: 
  • Dr. Brijesh Mehta performed what is believed to be the first live-streamed endovascular neurosurgery to fully secure a complex brain aneurysm using the novel Microvention Woven EndoBridge (WEB) device.
  • - Dr. Brijesh Mehta, Memorial Neuroscience Institute
    Dr. Mehta, a vascular interventional neurologist and medical director of the Comprehensive Stroke and Neurointerventional Surgery programs at the Memorial Neuroscience Institute, performed the first live-streamed endovascular neurosurgery to fully secure a complex brain aneurysm using the novel Microvention Woven EndoBridge (WEB) device.
  • The catheter-based image navigation procedure enabled the placement of the WEB device to secure the aneurysm.
  • Memorial Neuroscience Institute offers advanced diagnoses, comprehensive treatment, compassionate care, and rehabilitation for complex neurological conditions.

The Inner Circle Acknowledges, Harshpal Singh, MD, FAANS as a Distinguished Healthcare Professional for his contributions to the Neurological Field

Retrieved on: 
Wednesday, September 27, 2023
Spinal fusion, Icahn School of Medicine at Mount Sinai, University, Education, Tetraplegia, Neurosurgery, Laminectomy, Medical college, Neurology, Corpectomy, Medical College of Georgia, Deformity, Multimedia, Inner circle, Congress, American Board of Commissioners for Foreign Missions, Subarachnoid hemorrhage, Congress of Neurological Surgeons, American Association of Neurological Surgeons, MD, Patient, Mount Sinai School, Nerve, Myelopathy, Sport, Textbook, Neuro, Medical degree, Veterinary medicine, Dentistry, Spine, Augmented fifth, Medicine

ENGLEWOOD CLIFFS, N.J., Sept. 27, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Harshpal Singh, MD, FAANS is acknowledged as a Distinguished Healthcare Professional for his contributions to the Neurological Field.

Key Points: 
  • ENGLEWOOD CLIFFS, N.J., Sept. 27, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Harshpal Singh, MD, FAANS is acknowledged as a Distinguished Healthcare Professional for his contributions to the Neurological Field.
  • He completed a residency at Mount Sinai School of Medicine where he served as Chief Resident.
  • The doctor is also a specialist in spinal fusion; corpectomy; vertebroplasty; kyphoplasty; laminectomy; and difficult revision spinal surgery.
  • Aside from his professional pursuits, the doctor enjoys funding programs that distribute sports equipment to the disadvantaged in Punjab, India.

Brain Aneurysm Foundation Announces 2023 Research Grants

Retrieved on: 
Thursday, September 21, 2023
Subarachnoid hemorrhage, Bleeding, Therapy, Beth Israel Deaconess Medical Center, Education, Genetics, Prevalence, Blood, Epigenetics, Impact, Aneurysm, Stroke, Policy, Kick, Aortic rupture, Skull, Research, Risk, Brain, Biomarker, Pop, Science, SAH, ZIC3, BAF, Rupture, Robotics, HDAC2, Big data, Biology, Effectiveness, Diagnosis, Ecosystem, Role, Comparative effectiveness research, Health, Headache, Woman, Social media, Disease, Pharmaceutical industry, Mouse, Engagement

HANOVER, Mass., Sept. 21, 2023 /PRNewswire/ -- The Brain Aneurysm Foundation (BAF), the leading advocacy organization supporting education, research, and policy to transform the treatment of brain aneurysms, today announced the recipients of its 2023 research grants, providing support to academic researchers studying the underlying biology of aneurysms or developing new treatment methods.

Key Points: 
  • Provides Funding for 17 Research Efforts that aim to Address the Underlying Causes of Disease, New Treatment Paradigms and Key Markers of Ruptures and Hemorrhage
    Total Annual Research Funding Eclipses $5 million; BAF Kicks off its Annual Day of Engagement to Support its Mission of Reducing the Prevalence and Impact of Brain Aneurysms
    HANOVER, Mass., Sept. 21, 2023 /PRNewswire/ -- The Brain Aneurysm Foundation (BAF), the leading advocacy organization supporting education, research, and policy to transform the treatment of brain aneurysms, today announced the recipients of its 2023 research grants, providing support to academic researchers studying the underlying biology of aneurysms or developing new treatment methods.
  • Research grants are a cornerstone of the organization's mission, as it works to fund critical advances at a time where Federal dollars for brain aneurysm research amounts to just over $2 for every person afflicted.
  • A brain aneurysm is a weak, bulging area in an artery in the brain that in some instances can rupture.
  • Women over the age of 55 have a higher risk of brain aneurysm rupture than men and are generally at greater risk.

CereVasc eShunt® System Study Data Presented at the European Society of Minimally Invasive Neurological Therapy (ESMINT) Congress in Marseille

Retrieved on: 
Wednesday, September 13, 2023
Hydrocephalus, Sagrada Família, DSM-IV codes, Trial of the century, Congress, Subarachnoid hemorrhage, CH, Patient, Intracranial pressure, Pharmaceutical industry, Medical device

Trial data reporting the investigational use of the eShunt System in patients with hydrocephalus secondary to subarachnoid hemorrhage was presented by Ivan Lylyk, M.D., one of the lead investigators based at Clínica La Sagrada Familia in Buenos Aires, Argentina.

Key Points: 
  • Trial data reporting the investigational use of the eShunt System in patients with hydrocephalus secondary to subarachnoid hemorrhage was presented by Ivan Lylyk, M.D., one of the lead investigators based at Clínica La Sagrada Familia in Buenos Aires, Argentina.
  • The study, conducted under the leadership of Pedro Lylyk, M.D., represents the first-ever treatment with the eShunt System and the world's first endovascular treatment of CH.
  • "We are excited by the initial data demonstrating the potential to provide patients a minimally invasive treatment for communicating hydrocephalus.
  • The data presented at ESMINT bolster our confidence in the potential of the Company's minimally invasive treatment of hydrocephalus as we transition to the pivotal clinical trial in early 2024."

With One-in-Fifty People in the US at Risk, the Brain Aneurysm Foundation Launches New Campaign to Increase Disease Awareness and Accelerate Research

Retrieved on: 
Wednesday, September 6, 2023
Survivor, Fibromuscular dysplasia, Marfan syndrome, Beth Israel Deaconess Medical Center, Education, Prevalence, Blood, Stroke, Policy, Aortic rupture, Skull, Research, Brain, Risk, Pop, Pain, Subarachnoid hemorrhage, Polycystic kidney disease, BAF, Rupture, Patient, Physician, Need, Seizure, Nerve, Nausea, Biology, Diagnosis, City, Headache, Woman, Smoking, Death, Family, Memory, Social media, Autosome, Disease, Ehlers–Danlos syndromes, Pharmaceutical industry, Nursing, Aneurysm

HANOVER, Mass., Sept. 6, 2023 /PRNewswire/ -- The Brain Aneurysm Foundation (BAF), the leading advocacy organization supporting education, research, and policy to transform the treatment of brain aneurysms, today announced the launch of "Stop the Pop," a new campaign to increase awareness of the prevalence and impact of the disease and the need for ongoing investment to fund new innovations, screening, and treatment. 

Key Points: 
  • The campaign aims to build awareness of symptoms, genetic and environmental risk factors, and to increase research funding to better understand the underlying causes of the condition and to advance new treatments.
  • "A feeling that something has 'popped' is what we hear most from patients who have experienced a rupture.
  • A brain aneurysm is a weak, bulging area in an artery in the brain that in some instances can rupture.
  • Women over the age of 55 have a higher risk of brain aneurysm rupture than men and are generally at greater risk.